Cargando…
Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
BACKGROUND: Administration of onabotulinumtoxinA (BoNT-A) to peripheral tissues outside the calvaria reduces the number of days chronic migraine patients experience headache. Because the headache phase of a migraine attack, especially those preceded by aura, is thought to involve activation of menin...
Autores principales: | Zhang, XiChun, Strassman, Andrew M, Novack, Victor, Brin, Mitchell F, Burstein, Rami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959034/ https://www.ncbi.nlm.nih.gov/pubmed/26984967 http://dx.doi.org/10.1177/0333102416636843 |
Ejemplares similares
-
Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
por: Burstein, Rami, et al.
Publicado: (2014) -
Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats
por: Melo-Carrillo, Agustin, et al.
Publicado: (2019) -
Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023) -
Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors
por: Kerstein, Patrick C, et al.
Publicado: (2009) -
TRPA1 Mediates Mechanical Sensitization in Nociceptors during Inflammation
por: Lennertz, Richard C., et al.
Publicado: (2012)